Brand / product

Rozicon-M

Metformin + Rosiglitazone · 500 mg + 4 mg

₨ Official source-observed price PKR 506.00 14's

PKR 36.14 / tablet

✓ Official DRAP price source observed · Source checked 2026-11-13

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 36.14/ tablet

Price positionNo comparatorvs like-for-like peer median

Peer comparators0current-price listings

Normalized unit pricePKR 36.14 / tablet

No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Metformin + Rosiglitazone
Therapeutic area: Endocrine & metabolic
Drug class: Antidiabetic medicines
ATC: A10BD
Strength: 500 mg + 4 mg
Dosage form: Tablet
Pack: 14's
Registration no.: 057789
Price record verified: 2026-08-08
Latest DRAP source check: 2026-11-13 03:02

Manufacturer

Amarant Pharmaceuticals Private Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Summary

About Rozicon-M 500 mg + 4 mg tablet

Rozicon-M 500 mg + 4 mg tablet contains Metformin + Rosiglitazone 500 mg + 4 mg. It is registered with DRAP by Amarant Pharmaceuticals Private Limited (registration no. 057789). Its official price is PKR 506.00 for a pack of 14's, about PKR 36.14 per tablet. This price has applied since 23 July 2026. Rozicon-M is also available as 500 mg + 2 mg tablet. No other brand of Metformin + Rosiglitazone 500 mg + 4 mg in this form is listed in Pakistan.

Same brand

Other strengths of Rozicon-M

Rozicon-M 500 mg + 2 mgTablet · 14's · PKR 318.05

Alternatives (substitutes): same medicine, strength and form

Other brands of Metformin + Rosiglitazone 500 mg + 4 mg tablet in Pakistan

No other brand of Metformin + Rosiglitazone 500 mg + 4 mg tablet is listed in Pakistan. See all strengths and forms of Metformin + Rosiglitazone →

Where to buy

MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Rozicon-M, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.

Registration holder: Amarant Pharmaceuticals Private Limited, Karachi
DRAP registration: 057789
Phone: +92 21 35121361-63
Website: https://amarantpharma.com/
Contact page: Company contact page

Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (14's). Current price PKR 506.00, effective 23 Jul 2026.

Cite this price history

MedInfoBase. Rozicon-M 500 mg + 4 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rozicon-m-500-mg-4-mg-057789-14s-amarant-pharmaceuticals-private-limited/ (accessed 13 November 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 506.00	2026-07-23	2026-08-08	DRAP PharmaPrice Index	Current

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 057789

MedInfoBase. (2026). Rozicon-M 500 mg + 4 mg Tablet (14's), Amarant Pharmaceuticals Private Limited — registration and price record [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/brand/rozicon-m-500-mg-4-mg-057789-14s-amarant-pharmaceuticals-private-limited/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 057789.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.